Southeast Clinical Oncology Research Consortium Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 3,164,575 | 3,053,714 | 110,861 | 1.0 | 11% |
| 2012 | 2,480,652 | 2,500,410 | −19,758 | 1.1 | 14% |
| 2013 | 2,342,026 | 2,310,701 | 31,325 | 1.3 | 14% |
| 2014 | 1,890,752 | 1,909,256 | −18,504 | 1.5 | 15% |
| 2015 | 2,446,147 | 2,157,866 | 288,281 | 2.9 | 21% |
| 2016 | 3,254,826 | 3,409,430 | −154,604 | 1.2 | 12% |
| 2017 | 3,970,662 | 3,950,224 | 20,438 | 1.2 | 9% |
| 2018 | 0 | 0 | 0 | — | — |
| 2019 | 3,830,542 | 3,851,305 | −20,763 | 1.2 | 14% |
| 2020 | 3,113,240 | 3,090,489 | 22,751 | 1.6 | 17% |
| 2021 | 3,901,035 | 3,800,862 | 100,173 | 1.7 | 14% |
| 2022 | 3,111,390 | 3,118,144 | −6,754 | 2.0 | 18% |
| 2023 | 3,558,434 | 3,619,308 | −60,874 | 1.5 | 15% |
In its most recent public year (2023), this organization spent $60,874 more than it brought in. Its reserves stood at about 1.5 months of spending. Staff pay was 15% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Southeast Clinical Oncology Research Consortium Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works